Global Pharmaceutical Grade Lactose Market Size study & Forecast, by Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray Dried Lactose, Other Types) and Regional Analysis, 2023-2030

Global Pharmaceutical Grade Lactose Market Size study & Forecast, by Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray Dried Lactose, Other Types) and Regional Analysis, 2023-2030

Global Pharmaceutical Grade Lactose Market is valued at approximately USD 1.84 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.4% over the forecast period 2023-2030. Pharmaceutical grade lactose is created by oversaturating whey or permeating, a byproduct of the manufacturing of whey protein concentrate, with lactose, extracting the lactose crystals, purifying, drying, and grinding them. Pharmaceutical grade lactose is created to adhere to stringent requirements, including a spray-dried blend of crystalline and amorphous lactose for all purposes, a specified shape and size distribution, monohydrate, and crystalline, 40 mesh to 325 mesh. Every product complies with the standards of the American, European, and Japanese Pharmacopoeias. The key factors driving the market growth is increasing pharmaceutical industry, rising prevalence of chronic diseases, increasing use in dry powder inhalers (dpis), and growing preference for generic drugs that anticipated to support the market.

According to Statista, the sales of prescription drugs worldwide excluding generics and orphan drugs, from 2012 to 2026, in billion U.S. dollars. In 2012, sales for prescription drugs excluding generics and orphan stood at some 598 billion U.S. dollars which is estimated to increase up to over one trillion U.S. dollars in 2026. Globally, the pharmaceutical sector spent over 238 billion on research and development in 2021. In 2028, it's predicted to amount to USD 285 billion. Pharmaceutical R&D covers all phases of clinical trial development, including pre-clinical chemical testing and basic disease process research. A governmental authority becomes engaged at a given time in the procedure, often at the pre-clinical stage, to review, oversee, and finally approve the medicine. The Food and Drug Administration is the main organization in charge of procedures in the US. In addition, Advancements in Formulation, and increasing demand for automation in the pharmaceutical industry are major opportunities for the market. However, the high cost of pharmaceutical grade lactose is a major problem for the market.

The key regions considered for the Global Pharmaceutical Grade Lactose Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing pharmaceutical industry, growing demand for inhalation products, and rising prevalence of chronic diseases. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increased r&d activities, growth in generic drug manufacturing, rising healthcare needs, and growing R&D activities.

Major market player included in this report are:
Armor Proteines
BASF Corporation
Charotar Casein Company
DFE Pharma
Fengchen Group Co., Ltd
Alpavit
Kavya Pharma
Kerry Group plc
Lactalis Ingredients
Lactose (India) Limited

Recent Developments in the Market:
 In April 2023, The Laboratorios Prady Normapiel (Prady), a Spanish producer of fragrances and cosmetics for the personal care market, was acquired by the Surfachem Group. The 2M Group's continued expansion plan, which involves extending its worldwide presence and acquiring businesses that complement its current product line, includes the acquisition of Prady. The 2M Group of Companies is dedicated to giving customers outstanding service and high-quality specialty chemicals. The Group is in a good position to maintain its expansion and success in the global personal care sector thanks to the purchase of Prady.

Global Pharmaceutical Grade Lactose Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Type, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Crystalline Monohydrate Lactose
Inhalation Lactose
Granulated Lactose
Spray Dried Lactose
Other Types

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Armor Proteines
BASF Corporation
Charotar Casein Company
DFE Pharma
Fengchen Group Co., Ltd
Alpavit
Kavya Pharma
Kerry Group plc
Lactalis Ingredients
Lactose (India) Limited

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.